Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Cash from Financing Activities (2018 - 2026)

Alector's (ALEC) quarterly Cash from Financing Activities came in at $50000.0 in Q2 2026, down 59.02% year-over-year from $122000.0 in Q2 2025, and up 100.0% quarter-over-quarter from $25000.0 in Q1 2026.

Analysis

Alector (ALEC) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Cash from Financing Activities for 9 consecutive years, with $50000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 59.02% year-over-year to $50000.0 in Q2 2026; TTM through Jun 2026 was $20.2 million, a 103.51% increase from a year earlier, with the FY2025 full-year figure at $20.2 million, down 75.21% from the prior year.
  • Cash from Financing Activities was $50000.0 for Q2 2026 at Alector, up from $25000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $71.1 million in Q1 2024 and troughed at $25000.0 in Q1 2026.
  • A 5-year average of $7.3 million and a median of $881000.0 in 2023 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities tumbled 96.7% in 2022 and jumped 6490.18% in 2024, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at $636000.0 in 2022, then retreated by 7.23% to $590000.0 in 2023, then jumped by 1558.98% to $9.8 million in 2024, then slumped by 44.91% to $5.4 million in 2025, then tumbled by 99.07% to $50000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at $50000.0 (Q2 2026), $25000.0 (Q1 2026), and $5.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -1.48 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 2.34 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -426.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -1.22 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 14.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 36.24 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 1.30 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 27.18 Mn
10 Alector 274.68 Mn 101.88 Mn - 50,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50,000.00
Mar 31, 2026 25,000.00
Dec 31, 2025 5.39 Mn
Sep 30, 2025 14.70 Mn
Jun 30, 2025 122,000.00
Dec 31, 2024 9.79 Mn
Jun 30, 2024 644,000.00
Mar 31, 2024 71.11 Mn
Dec 31, 2023 590,000.00
Jun 30, 2023 881,000.00
Mar 31, 2023 1.08 Mn
Dec 31, 2022 636,000.00
Sep 30, 2022 489,000.00
Jun 30, 2022 906,000.00
Mar 31, 2022 2.48 Mn
Dec 31, 2021 8.64 Mn
Sep 30, 2021 14.82 Mn
Jun 30, 2021 2.96 Mn
Mar 31, 2021 3.87 Mn
Dec 31, 2020 1.10 Mn